X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (36) 36
index medicus (36) 36
humans (30) 30
rix-fp (26) 26
fc fusion protein (25) 25
hemophilia (21) 21
half-life (20) 20
safety (20) 20
albumin rix-fp (19) 19
coagulation-factor ix (18) 18
factor ix (17) 17
pharmacokinetics (17) 17
peripheral vascular disease (16) 16
factor ix - therapeutic use (15) 15
hemophilia b - drug therapy (15) 15
prophylaxis (15) 15
albumin (13) 13
animals (13) 13
hemophilia a - drug therapy (13) 13
recombinant factor-ix (13) 13
factor ix - pharmacokinetics (12) 12
hemophilia b (12) 12
pharmacokinetic properties (12) 12
previously treated patients (12) 12
factor viii - therapeutic use (11) 11
recombinant fusion proteins - pharmacokinetics (11) 11
recombinant fusion proteins - therapeutic use (11) 11
efficacy (10) 10
factor-viii (10) 10
prothrombin complex concentrate (10) 10
recombinant factor-viii (10) 10
extended half-life (8) 8
hemorrhage - prevention & control (8) 8
coagulation-factor-ix (7) 7
factor viii - pharmacokinetics (7) 7
haemophilia (7) 7
haemophilia b (7) 7
male (7) 7
care and treatment (6) 6
coagulation factors (6) 6
factor pathway inhibitor (6) 6
prolonged activity (6) 6
adolescent (5) 5
adult (5) 5
blood coagulation factors - pharmacokinetics (5) 5
blood coagulation factors - therapeutic use (5) 5
chain factor-viii (5) 5
child (5) 5
factor ix - administration & dosage (5) 5
factor ix - genetics (5) 5
factor viii (5) 5
hemophilia a - blood (5) 5
hemostasis - drug effects (5) 5
pegylated factor-viii (5) 5
pharmacology & pharmacy (5) 5
prolonged half-life (5) 5
proteins (5) 5
severe hemophilia-a (5) 5
albumin fusion (4) 4
b patients (4) 4
beta pegol n9-gp (4) 4
blood coagulation factor viii (4) 4
blood coagulation factors (4) 4
clinical trials as topic (4) 4
factor-ix (4) 4
hemophilia a - therapy (4) 4
hemophilia b - physiopathology (4) 4
hemophilia-b (4) 4
inhibitors (4) 4
middle aged (4) 4
nonacog beta pegol (4) 4
phase-3 trial (4) 4
quality of life (4) 4
review article (4) 4
therapy (4) 4
treatment outcome (4) 4
trial (4) 4
young adult (4) 4
activated factor-vii (3) 3
albumins - genetics (3) 3
antibodies, neutralizing - blood (3) 3
blood coagulation factors - administration & dosage (3) 3
children (3) 3
chromogenic assays (3) 3
clearance (3) 3
clinical trials (3) 3
coagulants - pharmacokinetics (3) 3
coagulants - therapeutic use (3) 3
coagulation factor ix (3) 3
factor ix - adverse effects (3) 3
factor ix - chemistry (3) 3
factor ix - metabolism (3) 3
factor viia (3) 3
factor viii - chemistry (3) 3
fusion protein (3) 3
gene-therapy (3) 3
glycopegylated factor-ix (3) 3
hematology, oncology and palliative medicine (3) 3
hemophilia b - therapy (3) 3
hemophilia-b patients (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 2016, Volume 115, Issue 10, pp. 659 - 668
Summary A global phase 3 study evaluated the pharmacokinetics, efficacy and safety of a recombinant fusion protein linking coagulation factor IX with albumin... 
Coagulation and Fibrinolysis
Journal Article
Journal Article
HAMOSTASEOLOGIE, ISSN 0720-9355, 05/2017, Volume 37, Issue 2, pp. 158 - 159
Journal Article
Journal Article
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 01/2019, Volume 17, Issue 1, pp. 138 - 148
Summary Essentials Performance of the one‐stage clotting (OSC) assay varies with the clotting activator used. Recombinant FIX‐albumin fusion protein (rIX‐FP)... 
multicenter study | factor IX | activated partial thromboplastin time | blood coagulation tests | hemophilia B | DISCREPANCIES | factor IX | DIAGNOSIS | hemophilia B | PERIPHERAL VASCULAR DISEASE | CHROMOGENIC ASSAYS | MODIFIED FACTOR-VIII | RIX-FP | HEMATOLOGY | Thromboplastin | Coagulation factors | Proteins | Fc receptors | Coagulation factor IX | Laboratories | Actin | Hemophilia | Albumin | Fusion protein | Clotting | Kaolin
Journal Article
Journal Article
Haemophilia, ISSN 1351-8216, 01/2019, Volume 25, Issue 1, pp. e11 - e18
Introduction The variety of treatment for haemophilia B (HB) has recently improved with the emergence of both AAV‐based gene therapy and bioengineered human... 
Fc fusion | haemophilia | factor IX | adeno‐associated virus | gene therapy | albumin fusion | adeno-associated virus | VIRUS | EFFICACY | SAFETY | TRANSDUCTION | PHASE-3 | RIX-FP | ADENOASSOCIATED VIRAL VECTORS | ALBUMIN | MUTATIONS | HEMATOLOGY | Coagulation factors | Proteins | Fc receptors | Secretion | Liver | Hemophilia | Plasma levels | Gene therapy | Transgenes | Expression vectors
Journal Article